
DCP backs China expansion by Canadian vitamins brand

DCP Capital has agreed to invest approximately USD 175m to support the China expansion of Jamieson Wellness, a listed Canadian producer of health and wellness products.
The China-focused GP will pay USD 35m for a one-third stake in Jamieson’s China operation and subscribe to USD 75m worth of preferred shares in Jamieson itself. In addition, DCP will subscribe to warrants...
Latest News
Japan's Heartseed raises $14m Series D
Heartseed, a Tokyo-based biotech start-up specializing in treatments that use cardiac muscle cells to initiate the remuscularization of patients who have suffered heart failure, has raised JPY 2bn (USD 14.3m) in Series D funding.
Shenzhen Capital backs Chinese titanium metal producer
Shenzhen Capital Group has participated in a CNY 2.27bn (USD 321m) funding round for Yunnan National Titanium Metal, a subsidiary of Shenzhen-listed chemicals producer LB Group.
Indonesia e-commerce player Evermos gets $39m Series C
The International Finance Corporation (IFC) has led a USD 39m Series C round for Evermos, an Indonesian social commerce platform that positions itself as an impact play.
Singapore's Qualgro seeks $150m for Fund III
Qualgro Partners, a Singapore-headquartered venture capital firm, is looking to raise USD 150m for its third fund.